Versant Capital Management’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-34
Closed -$559 2833
2026
Q1
$559 Sell
34
-20
-37% -$491 ﹤0.01% 2716
2025
Q4
$1.54K Sell
54
-99
-65% -$2.68K ﹤0.01% 2476
2025
Q3
$4.51K Sell
153
-381
-71% -$10.4K ﹤0.01% 2244
2025
Q2
$15.4K Buy
534
+450
+536% +$13.3K ﹤0.01% 1671
2025
Q1
$2.94K Sell
84
-149
-64% -$6.08K ﹤0.01% 2207
2024
Q4
$10.4K Sell
233
-341
-59% -$13.9K ﹤0.01% 1375
2024
Q3
$26.2K Buy
574
+460
+404% +$18.6K 0.01% 705
2024
Q2
$3.79K Buy
114
+69
+153% +$2.82K ﹤0.01% 1307
2024
Q1
$2.16K Buy
45
+35
+350% +$2.04K ﹤0.01% 1323
2023
Q4
$737 Sell
10
-11
-52% -$744 ﹤0.01% 1589
2023
Q3
$1.53K Buy
21
+5
+31% +$399 ﹤0.01% 1397
2023
Q2
$1.33K Buy
16
+6
+60% +$525 ﹤0.01% 1519
2023
Q1
$891 Hold
10
﹤0.01% 1472
2022
Q4
$857 Hold
10
﹤0.01% 1329
2022
Q3
$1K Sell
10
-4
-29% -$358 ﹤0.01% 1322
2022
Q2
$1K Sell
14
-3
-18% -$306 ﹤0.01% 1339
2022
Q1
$2K Buy
17
+7
+70% +$746 ﹤0.01% 1173
2021
Q4
$1K Hold
10
﹤0.01% 1327
2021
Q3
$1K Hold
10
﹤0.01% 1348
2021
Q2
$1K Hold
10
﹤0.01% 1347
2021
Q1
$1K Hold
10
﹤0.01% 1422
2020
Q4
$1K Hold
10
﹤0.01% 1247
2020
Q3
$2K Sell
10
-2
-17% -$446 ﹤0.01% 1092
2020
Q2
$2K Hold
12
﹤0.01% 1087
2020
Q1
$1K Hold
12
﹤0.01% 1188
2019
Q4
$0 Hold
12
﹤0.01% 1538
2019
Q3
$0 Buy
+12
New +$722 ﹤0.01% 1544

Other funds holding QDEL

Versant Capital Management's QDEL Position: Q2 2026 in Review

Versant Capital Management sold out of QuidelOrtho (QDEL) in Q2 2026, closing a stake of 34 shares — an estimated $559 sold.

Versant Capital Management first reported a position in QDEL in Q3 2019 and held it in 27 quarters. The position peaked at $26.2K in Q3 2024. 20 funds tracked by Wall St. Rank hold QDEL as of Q2 2026.

  • Versant Capital Management reported no remaining QuidelOrtho position as of Q2 2026 after selling out during the quarter.
  • Versant Capital Management sold 34 QuidelOrtho shares in Q2 2026, an estimated $559.
  • Versant Capital Management first reported a position in QuidelOrtho in Q3 2019 and held it in 27 quarters.
  • Versant Capital Management's QuidelOrtho position peaked at $26.2K in Q3 2024.
  • 20 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.